PharmaTimes April 22, 2022
Lina Adams

Researchers were able to detect specific combinations of genetic alterations which may hold key to the growth of cancers

UK scientists are currently analysing the complete genetic make-up – or whole genome sequence – of tumours from about 12,000 patients in the country.

The team says that the unprecedented amount of data allowed them to discover new patterns in the DNA of cancer, hinting at causes that are not yet understood. They add that the genetic clues are likely to help improve diagnosis and treatment.

The research is published in Science and led by the University of Cambridge. The research team analysed anonymised DNA data provided by the 100,000 Genomes Project – a nationwide initiative to sequence the whole genomes...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Pharma / Biotech, Physician, Precision Medicine, Provider
Putting Patients First by Extending the Reach of World-Class Care
Healthcare's most promising tech
AI In Healthcare: A New Era Of Personalized Patient Care
23andMe reports sales decline a day after announcing plans to cut 40% of workforce
Patient-derived organoids: Transforming cancer research and personalized medicine

Share This Article